Drug Trial Radar · NCT02603432
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Last checked: Nov 20, 2026Latest source record: Mar 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
700
Actual
Start
Apr 25, 2016
Primary completion
Oct 21, 2019
Study completion Mar 28, 2023
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Nov 11, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to compare maintenance treatment with avelumab plus best supportive care (BSC) with BSC alone, to determine if avelumab has an effect on survival in patients with locally advanced or metastatic urothelial cancer that did not worsen during or following completion of first-line chemotherapy.
Conditions
- Urothelial Cancer
Interventions
AvelumabBiological
1 hour intravenous infusion every 2 weeks (Q2W) in 4 week cycles
Best Supportive CareOther
BSC will be administered as deemed appropriate by the treating physician, and could include treatment with antibiotics, nutritional support, correction of metabolic disorders, optimal symptom control and pain management (including palliative radiotherapy), etc. BSC does not include any active anti-tumor therapy, however local radiotherapy of isolated lesions with palliative intent is acceptable.
Following the planned interim analysis for this study: AvelumabBiological
1 hour intravenous infusion every 2 weeks (Q2W) in 4 week cycles
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: From randomization to discontinuation from the study, death or date of censoring, whichever occurred first (for a maximum duration of 41 months)
Locations
382 sites in 29 countries. Site status is shown where the registry gives one.
Anschutz Cancer Center Pavilion Pharmacy
Aurora, Colorado
University of Colorado Cancer Center
Aurora, Colorado
University of Colorado Denver, CTO (CTRC)
Aurora, Colorado
University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP)
Aurora, Colorado
University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)
Aurora, Colorado
Smilow Cancer Hospital at Yale New Haven
New Haven, Connecticut
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut
Massachusetts General Hospital
Boston, Massachusetts
University of Minnesota Medical Center
Minneapolis, Minnesota
University of Minnesota
Minneapolis, Minnesota
Cleveland Clinic Taussing Cancer Center
Cleveland, Ohio
Cleveland Clinic Taussing Cancer Center
Cleveland, Ohio
Cleveland Clinic Foundation
Cleveland, Ohio
Cleveland Clinic Taussing Cancer Center
Cleveland, Ohio
Inova Schar Cancer Institute Infusion Pharmacy
Fairfax, Virginia
Inova Schar Cancer Institute
Fairfax, Virginia
Seattle Cancer Care Alliance
Seattle, Washington
Seattle Cancer Care Alliance
Seattle, Washington
University of Washington Medical Center
Seattle, Washington
Fundación CENIT para la Investigación en Neurociencias
CABA, Argentina
GP Diagnostico SRL
La Rioja, Argentina
Hospital Regional Dr. Enrique Vera Barros
La Rioja, Argentina
Instituto del Diagnostico
La Rioja, Argentina
Centro Oncologico Riojano Integral (Cori)
La Rioja, Argentina
Centro de Investigacion Pergamino S.A.
Pergamino, Buenos Aires, Argentina
Slade Health
Mount Waverley, Australia
Macquarie Heart
New South Wales, Australia
Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
Concord Hospital
Concord, New South Wales, Australia
Dubbo Base Hospital
Dubbo, New South Wales, Australia
Ramsay Pharmacy
Kogarah, New South Wales, Australia
St George Private Hospital
Kogarah, New South Wales, Australia
Epic Pharmacy
Lismore, New South Wales, Australia
North Coast Radiology St Vincents
Lismore, New South Wales, Australia
Northern Rivers Pathology Service
Lismore, New South Wales, Australia
St Vincent's Pathology Lismore
Lismore, New South Wales, Australia
Macquarie Medical Imaging
Macquarie University, New South Wales, Australia
Macquarie University Hospital Pharmacy
Macquarie University, New South Wales, Australia
Macquarie University
Macquarie University, New South Wales, Australia
The Murwillumbah Hospital
Murwillubah, New South Wales, Australia
Showing 40 of 382 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.